MilliporeSigma is your provider for confidently advancing your drug pipeline from discovery to market. We extend your capabilities by combining our scientific knowledge, regulatory expertise and flexibility, with the trusted, relevant information required for your drug discovery and development needs.
GPCRs: HTS-quality ChemiScreen™ membrane preps, Ready-to-Assay™ frozen cells for drug screening and profiling
Ion Channels: hERG membrane preparations for cardiotoxicity assessment
Kinases & Phosphatases: Upstate® enzymes and HTRF® assay kits for drug discovery
Ubiquitin: Remove the complexity of ubiquitin signaling with active enzymes and assays for 20+ ubiquitin pathways
ADME & in vitro Toxicology: HepaRG™ terminally differentiated cells that express native transporters and drug metabolizing enzymes
Strat-M® Transdermal Diffusion Membrane: Experience the unmatched predictability of Strat-M® membrane — a synthetic, non-animal based model for transdermal diffusion testing that is predictive of diffusion in human skin without lot-to-lot variability, safety and storage limitations.
Discovery & Bioanalytical Services
These services are now part of Eurofins.
|
Visit the Eurofins site for Bioanalytical Services
- Biomarker Analysis
- Immunogenicity Testing
- Pharmacokinetics Testing
- cGMP Services
- Biosimilar Testing
|
Featured Resources
Featured Webinar Clinical Flow Cytometry Outsourcing
Topic: Flow Cytometry Analysis of Clinical Trial Samples
Speaker: Kevin Maskell, Principal Scientific Director, Discovery & Development Solutions, MilliporeSigma
|
Featured Applications Detecting Substrate Ubiquitination Using Quantitative Assays
|